ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: A novel multifunctional microchip was developed and used to detect BCR-ABL1, the fusion transcript responsible for Chronic Myeloid Leukemia (CML), directly from total RNA extracted from cells, via colorimetric Au-nanoprobe non-cross-linking assay.